York Charles N Ii - Net Worth and Insider Trading
York Charles N Ii Net Worth
The estimated net worth of York Charles N Ii is at least $4 Million dollars as of 2024-05-14. York Charles N Ii is the COO, CFO AND SECRETARY of Day One Biopharmaceuticals Inc and owns about 217,293 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $3 Million. York Charles N Ii is also the CFO and VP of Spyre Therapeutics Inc and owns about 1,391 shares of Spyre Therapeutics Inc (SYRE) stock worth over $51,467. Details can be seen in York Charles N Ii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that York Charles N Ii has not made any transactions after 2024-05-03 and currently still holds the listed stock(s).
Transaction Summary of York Charles N Ii
York Charles N Ii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, York Charles N Ii owns 2 companies in total, including Spyre Therapeutics Inc (SYRE) , and Day One Biopharmaceuticals Inc (DAWN) .
Click here to see the complete history of York Charles N Ii’s form 4 insider trades.
Insider Ownership Summary of York Charles N Ii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2017-12-05 | Chief Financial Officer and VP |
| DAWN | Day One Biopharmaceuticals Inc | 2024-05-03 | COO & CFO and Secretary |
York Charles N Ii Latest Holdings Summary
York Charles N Ii currently owns a total of 2 stocks. Among these stocks, York Charles N Ii owns 217,293 shares of Day One Biopharmaceuticals Inc (DAWN) as of May 3, 2024, with a value of $3 Million and a weighting of 98.55%. York Charles N Ii also owns 1,391 shares of Spyre Therapeutics Inc (SYRE) as of December 5, 2017, with a value of $51,467 and a weighting of 1.45%.
Latest Holdings of York Charles N Ii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-05-03 | 217,293 | 16.05 | 3,487,553 |
| SYRE | Spyre Therapeutics Inc | 2017-12-05 | 1,391 | 37.00 | 51,467 |
Holding Weightings of York Charles N Ii
York Charles N Ii Form 4 Trading Tracker
According to the SEC Form 4 filings, York Charles N Ii has made a total of 19 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 60,461 shares on May 3, 2024, which brought York Charles N Ii around $1 Million.
According to the SEC Form 4 filings, York Charles N Ii has made a total of 0 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years. The most-recent trade in Spyre Therapeutics Inc is the acquisition of 1,038 shares on December 5, 2017, which cost York Charles N Ii around $116,296.
Insider Trading History of York Charles N Ii
- 1
York Charles N Ii Trading Performance
GuruFocus tracks the stock performance after each of York Charles N Ii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by York Charles N Ii is 62.24%. GuruFocus also compares York Charles N Ii's trading performance to market benchmark return within the same time period. The performance of stocks bought by York Charles N Ii within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how York Charles N Ii's insider trading performs compared to the benchmark.
Performance of York Charles N Ii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.46 | | | | | |
| Relative Return to S&P 500(%) | 12.14 | | | | | |
York Charles N Ii Ownership Network
York Charles N Ii Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
York Charles N Ii is the Chief Financial Officer and VP of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
York Charles N Ii Mailing Address
Above is the net worth, insider trading, and ownership report for York Charles N Ii. You might contact York Charles N Ii via mailing address: 901 S. Mopac Expressway, Barton Oaks Plaza One, Suite 250, Austin Tx 78746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
